Cohort study analyzes the impact of FTC actions on pharmaceutical patent protection, indicating significant changes in patent periods.
This cohort study evaluates all products targeted by the Federal Trade Commission from 2023 to 2025 and analyzes how delistings have impacted periods of patent protection.
No takes yet. Share an insight, caveat, or question.
Leon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: